triazoles has been researched along with Encephalopathy, Toxic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; Guo, D; He, R; Luo, L; Zhang, W | 1 |
| Ahmadie, NE; Aristizabal-Henao, JJ; Bowden, JA; Kroyter, N; Martyniuk, CJ; Nguyen, KT; Pena-Delgado, CJ; Sanchez, CL; Souders, CL | 1 |
| Li, FX; Li, L; Li, YJ; Liu, ZT; Xu, SY; Yu, XJ; Zhao, W | 1 |
| Barbaz, M; Bellissant, E; Lemaitre, F; Scailteux, LM; Tadié, JM; Uhel, F; Verdier, MC | 1 |
| Chang, J; Garner, CE; Huang, C; Ichihara, G; Ichihara, S; Ito, H; Kato, M; Sakurai, T; Toyokuni, S; Zhang, L; Zhang, X; Zong, C | 1 |
| Das, S; Smid, SD | 1 |
| Pea, F; Viale, P | 1 |
| Agostinho, PM; Cognato, GP; Cunha, RA; Hockemeyer, J; Müller, CE; Souza, DO | 1 |
| Jain, S; Kapoor, G | 1 |
| Bortolatto, CF; Jesse, CR; Nogueira, CW; Wilhelm, EA | 1 |
| Deng, XQ; Quan, ZS; Shu, B; Wang, SB; Zheng, Y | 1 |
| Bian, M; Deng, XQ; Quan, ZS; Wang, SB; Zheng, Y | 1 |
| Amoiridis, G; Kalmanti, M; Kondi, A; Mantadakis, E | 1 |
13 other study(ies) available for triazoles and Encephalopathy, Toxic
| Article | Year |
|---|---|
Enantioselective acute toxicity, oxidative stress effects, neurotoxicity, and thyroid disruption of uniconazole in zebrafish (Danio rerio).
Topics: Acetylcholinesterase; Animals; Ecosystem; Molecular Docking Simulation; Neurotoxicity Syndromes; Oxidative Stress; Stereoisomerism; Thyroid Gland; Triazoles; Water Pollutants, Chemical; Zebrafish | 2022 |
Neurotoxicity assessment of triazole fungicides on mitochondrial oxidative respiration and lipids in differentiated human SH-SY5Y neuroblastoma cells.
Topics: Cell Line, Tumor; Energy Metabolism; Fungicides, Industrial; Humans; Lipid Metabolism; Lipidomics; Membrane Potential, Mitochondrial; Mitochondria; Neurons; Neurotoxicity Syndromes; Oxidation-Reduction; Triazoles | 2020 |
Activation of p47phox as a Mechanism of Bupivacaine-Induced Burst Production of Reactive Oxygen Species and Neural Toxicity.
Topics: Animals; Benzoxazoles; Bupivacaine; Cell Line, Tumor; Cell Membrane; Male; NADPH Oxidases; Neurotoxicity Syndromes; Protein Transport; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Respiratory Burst; Triazoles | 2017 |
A case-report of unpredictable and massive voriconazole intoxication in a patient with extensive CYP2C19 and CYP2C9 polymorphisms.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Drug Monitoring; Half-Life; Humans; Male; Neurotoxicity Syndromes; Pyrimidines; Triazoles; Voriconazole | 2013 |
Preliminary characterization of a murine model for 1-bromopropane neurotoxicity: Role of cytochrome P450.
Topics: Animals; Atmosphere Exposure Chambers; Cerebral Cortex; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; Hydrocarbons, Brominated; Injections, Intraperitoneal; Injections, Subcutaneous; Liver; Male; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Neurotoxicity Syndromes; Organ Size; ran GTP-Binding Protein; Solvents; Triazoles | 2016 |
Identification of dibenzyl imidazolidine and triazole acetamide derivatives through virtual screening targeting amyloid beta aggregation and neurotoxicity in PC12 cells.
Topics: Amyloid beta-Peptides; Animals; Cell Survival; Computer Simulation; Drug Evaluation, Preclinical; Imidazolidines; Microscopy, Electron, Transmission; Molecular Docking Simulation; Molecular Targeted Therapy; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; PC12 Cells; Rats; Triazoles | 2017 |
Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?
Topics: Antifungal Agents; Drug Monitoring; Hallucinations; Humans; Neurotoxicity Syndromes; Pyrimidines; Risk Assessment; Triazoles; Voriconazole | 2009 |
Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Animals, Newborn; Caffeine; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Glial Fibrillary Acidic Protein; Kainic Acid; Memory Disorders; Neurotoxicity Syndromes; Phosphodiesterase Inhibitors; Purines; Pyrimidines; Qa-SNARE Proteins; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures; Synapses; Synaptophysin; Synaptosomal-Associated Protein 25; Triazoles; Tritium; Xanthines | 2010 |
Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Humans; Male; Mucormycosis; Neurotoxicity Syndromes; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Triazoles; Vincristine | 2010 |
Selective blockade of A(2A) receptor protects against neurotoxicity induced by kainic acid in young rats.
Topics: Adenosine A2 Receptor Antagonists; Animals; Brain; Catalase; Glutathione Peroxidase; Glutathione Transferase; Kainic Acid; Male; Neurotoxicity Syndromes; Oxidative Stress; Pyrimidines; Rats; Reactive Oxygen Species; Seizures; Triazoles | 2012 |
Design, synthesis, and anticonvulsant activity evaluation of 4-(3-alkoxy-phenyl)-2,4-dihydro-[1,2,4]triazol-3-ones.
Topics: Animals; Anticonvulsants; Drug Design; Electroshock; Mice; Mice, Inbred Strains; Molecular Structure; Neurotoxicity Syndromes; Seizures; Triazoles | 2013 |
Synthesis and anticonvulsant activity evaluation of 5-phenyl-[1,2,4]triazolo[4,3-c]quinazolin-3-amines.
Topics: Amines; Animals; Anticonvulsants; Drug Design; Electroshock; Mice; Mice, Inbred Strains; Molecular Structure; Neurotoxicity Syndromes; Quinazolines; Rotarod Performance Test; Seizures; Triazoles | 2013 |
Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Demyelinating Diseases; Electromyography; Fever; Humans; Lung Diseases; Male; Neural Conduction; Neurotoxicity Syndromes; Neutropenia; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Triazoles; Vincristine | 2007 |